CryptoCISO

Capital Infusion – Fraud Indicators & Recovery Guidance

CryptoCISO Risk Verdict
High Risk · Score 74/100
Forensic assessment of Capital Infusion by the CryptoCISO blockchain intelligence team.

Threat Profile

Capital Infusion (an unverified domain) positions itself as a digital-asset brokerage targeting everyday investors. It was escalated to forensic review following recurring complaint signatures.

Regulatory Posture

On the regulatory side, Capital Infusion provides no verifiable licensing details. We could not match the operator to any recognised financial regulator, and the absence of a supervising authority means deposits carry no statutory safeguard.

On-Chain & Operational Notes

From a forensic standpoint, deposits routed to operators like Capital Infusion are typically swept quickly through intermediary wallets and into mixing services or high-risk exchanges. Acting early – before funds are layered – materially affects what can be traced.

Indicators We Flagged

  • Withdrawal friction reported – delays, surprise ‘fees’, or frozen balances
  • Crypto-only deposits that bypass chargeback protections
  • Account managers steering clients toward larger top-ups
  • No verifiable licence from a top-tier financial regulator
  • Cloned or template website design shared with other flagged operators

CryptoCISO Risk Verdict

On balance, Capital Infusion carries a high risk profile. The evidence points away from a legitimate, supervised brokerage and toward an operation structured to retain deposits.

If Your Funds Are Exposed

Should you be exposed, halt further payments and ignore demands for upfront fees to ‘free’ your balance. Gather your evidence – TXIDs, wallet addresses, screenshots, and correspondence – while it is still accessible. Early, organised evidence is what makes downstream tracing and reporting viable.

Request a confidential CryptoCISO assessment →